World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
46
Citations
6206
World Ranking
16198
National Ranking
4036

Kenneth W. Turteltaub publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Kenneth W. Turteltaub sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 157 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Kenneth W. Turteltaub D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth W. Turteltaub sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 46 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Kenneth W. Turteltaub is affiliated with Lawrence Livermore National Laboratory in the United States. Their research spans multiple fields including Biochemistry, Genetics and Molecular Biology, Environmental Science, and Medicine, with a particular focus on Health, Toxicology and Mutagenesis, Cancer Research, Pathology and Forensic Medicine, Oncology, and Molecular Biology.

The primary topics covered in Kenneth W. Turteltaub's work include:

  • Carcinogens and Genotoxicity Assessment
  • Toxic Organic Pollutants Impact
  • Effects and risks of endocrine disrupting chemicals
  • Cancer, Lipids, and Metabolism
  • Metal complexes synthesis and properties
  • Genetic factors in colorectal cancer
  • Genomics, phytochemicals, and oxidative stress

Their recent research publications include:

  • Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP, 2021, Environment International
  • Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy, 2020, Molecular Cancer Therapeutics
  • Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing, 2023, Chemico-Biological Interactions
  • Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-diindolylmethane (DIM) or Brussels sprouts, 2023, Toxicology and Applied Pharmacology
  • P165 - Improved on-line accelerator mass spectrometry techniques for the analysis of environmental chemicals at ultra-low exposure levels, 2020, Drug Metabolism and Pharmacokinetics

Frequent coauthors in their body of work include:

  • Ted Ognibene
  • David E. Williams
  • Monica L. Vermillion Maier
  • Lisbeth K. Siddens
  • Jamie Pennington

The main publication venues for Kenneth W. Turteltaub's work are:

  • Environment International
  • Molecular Cancer Therapeutics
  • Chemico-Biological Interactions
  • Toxicology and Applied Pharmacology
  • Drug Metabolism and Pharmacokinetics

Best Publications

  • Accelerator Mass Spectrometry

    John S. Vogel;Kenneth W. Turteltaub;Robert Finkel;D. Erie Nelson

  • Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.

    Ken W Turteltaub;J. S. Felton;B. L. Gledhill;J. S. Vogel

  • DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

    Karen H. Dingley;Kellie D. Curtis;Susan Nowell;James S. Felton

  • Methods of DNA adduct determination and their application to testing compounds for genotoxicity.

    D. H. Phillips;P. B. Farmer;F. A. Beland;R. G. Nath

  • LLNL/UC AMS facility and research program

    J. C. Davis;I. D. Proctor;J. R. Southon;M. W. Caffee

  • Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA.

    Michael H. Buonarati;Kenneth W. Turteltaub;Nancy H. Shen;James S. Felton

  • Effects of Chlorophyll and Chlorophyllin on Low-Dose Aflatoxin B1 Pharmacokinetics in Human Volunteers

    Carole Jubert;John Mata;Graham Bench;Roderick Dashwood

  • The identification of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans

    Michael A. Malfatti;Kristen S. Kulp;Mark G. Knize;Cindy Davis

  • Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.

    David J. Boocock;Karen Brown;Anthony H. Gibbs;Esther Sanchez

  • Bioanalytical Applications of Accelerator Mass Spectrometry for Pharmaceutical Research

    Ken W Turteltaub;John S. Vogel

  • Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses.

    Kenneth W Turteltaub;Karen H Dingley;Kellie D Curtis;Michael A Malfatti

  • Single sample extraction protocol for the quantification of NAD and NADH redox states in Saccharomyces cerevisiae

    Jennifer L. Sporty;Md. Mohiuddin Kabir;Kenneth W. Turteltaub;Ted Ognibene

  • MeIQx-DNA adduct formation in rodent and human tissues at low doses

    Kenneth W Turteltaub;Robert J Mauthe;Karen H Dingley;Karen H Dingley;John S Vogel

  • The Urinary Metabolite Profile of the Dietary Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Is Predictive of Colon DNA Adducts after a Low-Dose Exposure in Humans

    Michael A. Malfatti;Karen H. Dingley;Susan Nowell-Kadlubar;Esther A. Ubick

  • Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 mice.

    Moire Robertson Creek;Chitra Mani;Chitra Mani;John S. Vogel;Ken W Turteltaub

  • Dose-response studies of MeIQx in rat liver and liver DNA at low doses.

    Christopher E. Frantz;Christy Bangerter;Ester Fultz;Kathryn M. Mayer

  • The formation of AFB1-macromolecular adducts in rats and humans at dietary levels of exposure

    B. C. Cupid;T. J. Lightfoot;D. Russell;S. J. Gant

  • Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline in humans

    Robert J. Turesky;R. Colin Garner;Dieter H. Welti;Janique Richoz

  • Accelerator mass spectrometry for biomedical research.

    Karen Brown;Karen H Dingley;Kenneth W Turteltaub

  • Metabolism of food-derived heterocyclic amines in nonhuman primates

    Elizabeth G Snyderwine;Robert J Turesky;Kenneth W Turteltaub;Cindy D Davis

Frequent Co-Authors

James S. Felton
James S. Felton Lawrence Livermore National Laboratory
Robert J. Turesky
Robert J. Turesky University of Minnesota
Mark G. Knize
Mark G. Knize Lawrence Livermore National Laboratory
David E. Williams
David E. Williams Oregon State University
Robert C. Finkel
Robert C. Finkel Lawrence Livermore National Laboratory
Marc W. Caffee
Marc W. Caffee Purdue University West Lafayette
Stewart P.H.T. Freeman
Stewart P.H.T. Freeman University of Glasgow
Andrew J. Wyrobek
Andrew J. Wyrobek Lawrence Berkeley National Laboratory
Sally A. Amundson
Sally A. Amundson Columbia University
Peter B. Farmer
Peter B. Farmer University of Leicester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Chemistry in the USA, exploring related career pathways can open up diverse opportunities. Many choose to complement their education with specialized online programs. For example, pursuing a paralegal associate degree can offer a solid foundation for roles requiring legal knowledge alongside scientific expertise.

The pharmaceutical industry is another prominent field for chemistry graduates. Professionals often consider roles such as pharmaceutical sales representatives, where understanding the science behind products is crucial. If you're curious about compensation in this field, check out insights on pharmaceutical rep salary to gauge earning potential and career trajectory.

For those aiming higher academically, becoming a pharmacist is a rewarding pathway but requires significant commitment. Learn more about the extensive education and training by reading about how much schooling to be a pharmacist entails.

Alternatively, chemistry graduates interested in forensic science might explore becoming an autopsy technician. This specialized role involves critical lab work and offers unique job prospects, with detailed information on how much do autopsy techs make to help evaluate this career's viability.

Best Scientists Citing Kenneth W. Turteltaub

Trending Scientists

Recently Published Articles